Cedience

Cedience Inc. is a Toronto-based software company that builds a regulatory intelligence platform for drug and biologics development. The platform automatically centralizes and integrates the databases published by regulatory authorities — webpages, guidance documents, notices, regulations, product labels, product-specific assessments and reviews, correspondence, milestone meeting minutes, advisory committee deliberations and information requests — and applies natural language processing and machine learning so users can answer complex precedent questions in minutes rather than days.

Core product capabilities include keyword search across regulatory documents with filters for date range, document section, product, medical condition, biomarker and regulatory designation; side-by-side document comparison with automatic highlighting of differences and similarities; and configurable alerts that notify users when regulatory databases change. Users can annotate documents and extract data points, organize findings with tags, highlights and search logs, visualize and segment results using page filters such as platform trials or real-world evidence, and create shared document collections for team collaboration. The company also positions the platform for reconstructing product development timelines, showing the studies submitted and the events leading to regulatory decisions.

Published case studies describe using the platform to search boxed warning sections of product labels for hepatotoxicity warnings and then locate approved Risk Evaluation and Mitigation Strategies (REMS); to identify which Diffuse Large B Cell Lymphoma studies actually supported regulatory decisions; and to pinpoint regulator feedback on immunogenicity risk assessment of monoclonal antibodies within approved review packages. The site also cites example research questions with stated completion times of 10 to 30 minutes, such as which products relied on real-world data to support approval and which primary endpoints supported recent triple-negative breast cancer approvals.

Founding story

Cedience was founded by Amin Osmani, who serves as CEO, and Andy Nanopoulos, who serves as CTO; a 2022 MaRS article names Amin Osmani and Krish Perumal as founders. The team comprises software engineers, data scientists and regulatory affairs professionals focused on drug development challenges.

Business model

Cedience operates a SaaS platform sold to organizations, with a website conversion path built around scheduling a demo and starting a trial.

Traction

The platform covers approximately 8,045,092 regulatory pages across 44 regulatory databases and 10 regulatory agencies. During the Venture Lane Studio program, the company reported accelerating its sales cycle sixfold, a 700% increase in pipeline value and a 250% expansion of a client contract.

Latest developments

The company's website markets the platform with demo scheduling and trial sign-up, published case studies, and stated coverage of 44 regulatory databases across 10 agencies.